全文获取类型
收费全文 | 10127篇 |
免费 | 646篇 |
国内免费 | 165篇 |
专业分类
耳鼻咽喉 | 108篇 |
儿科学 | 609篇 |
妇产科学 | 957篇 |
基础医学 | 1068篇 |
口腔科学 | 40篇 |
临床医学 | 1020篇 |
内科学 | 1448篇 |
皮肤病学 | 46篇 |
神经病学 | 643篇 |
特种医学 | 285篇 |
外科学 | 666篇 |
综合类 | 866篇 |
预防医学 | 1622篇 |
眼科学 | 68篇 |
药学 | 758篇 |
3篇 | |
中国医学 | 37篇 |
肿瘤学 | 694篇 |
出版年
2024年 | 8篇 |
2023年 | 180篇 |
2022年 | 401篇 |
2021年 | 545篇 |
2020年 | 464篇 |
2019年 | 412篇 |
2018年 | 460篇 |
2017年 | 385篇 |
2016年 | 324篇 |
2015年 | 371篇 |
2014年 | 775篇 |
2013年 | 813篇 |
2012年 | 651篇 |
2011年 | 745篇 |
2010年 | 546篇 |
2009年 | 531篇 |
2008年 | 502篇 |
2007年 | 447篇 |
2006年 | 402篇 |
2005年 | 278篇 |
2004年 | 236篇 |
2003年 | 184篇 |
2002年 | 139篇 |
2001年 | 116篇 |
2000年 | 113篇 |
1999年 | 88篇 |
1998年 | 79篇 |
1997年 | 59篇 |
1996年 | 68篇 |
1995年 | 60篇 |
1994年 | 56篇 |
1993年 | 51篇 |
1992年 | 38篇 |
1991年 | 42篇 |
1990年 | 27篇 |
1989年 | 21篇 |
1988年 | 44篇 |
1987年 | 29篇 |
1986年 | 18篇 |
1985年 | 26篇 |
1984年 | 33篇 |
1983年 | 17篇 |
1982年 | 28篇 |
1981年 | 22篇 |
1980年 | 11篇 |
1979年 | 18篇 |
1978年 | 20篇 |
1977年 | 11篇 |
1976年 | 12篇 |
1971年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
应用拷贝数变异测序(copy number variation sequencing,CNV-seq)技术鉴别来源不明的胎儿标记染色体,明确其遗传物质的来源,并探讨此技术在产前诊断中的应用价值。讨论Pallister-Killian综合征(Pallister-Killian syndrome,PKS)的临床特征及遗传学特点,提高对此类罕见染色体疾病的认识。该病例因在妊娠中期超声发现胎儿异常而行羊水穿刺进行CNV-Seq检测,同时分析胎儿和父母的核型。羊水CNV-Seq结果示该样本12号染色体p13.33-p11.1处检测到拷贝数为3.5、片段大小为34.70 Mb的嵌合重复区域;羊水染色体核型结果为47,XY,+i(12)(p10)[58]/46,XX[42],综合上述结果考虑为PKS。通过结合超声结果,综合应用染色体G显带核型分析和CNV-seq技术能准确确认染色体异常片段来源,在产前有效诊断PKS患者。 相似文献
2.
《Revue d'épidémiologie et de santé publique》2020,68(1):33-36
BackgroundControversies around organized breast cancer screening emphasize the need for information for women. In France, the institute of cancer (INCa) is in charge of conveying this information. Cancer Rose's website (CR) provides complementary information considering INCa's incomplete. The objective of this study was to identify if these informations meet criteria for decision aid.MethodsInformation documents were selected and analyzed using International Patient Decision Aid Standards (IPDAS). Each item was noted A (absent), P (present) or I (present but incomplete).ResultsInformation booklet and press kit for INCa and studies section for CR were the document meeting most criteria. The document meeting fewer criteria were the INCa's video and information leaflet for CR. Videos are more accessible tools for people with lower levels of health literacy. INCa's video did not present the risks of screening and CR's emphasized the risks.ConclusionThese documents have not been evaluated for intelligibility, clarity and readability. Addressing these criteria limits social inequities and improves health literacy. 相似文献
3.
4.
5.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
6.
7.
《Vaccine》2021,39(34):4759-4765
Dengue vaccination would enhance the control of dengue, one of the most frequent vector-borne viral diseases globally. CYD-TDV is the first dengue vaccine to be licensed, but global uptake has been hampered due to its use being limited to seropositive persons aged 9 years and above, and the need for a 3-dose schedule. The Partnership for Dengue Control (PDC) organized a meeting with key opinion leaders and stakeholders to deliberate on implementation strategies for the use of CYD-TDV. New data have emerged that support the shortening of the primary schedule from a 3 to 2 dose schedule, extending the age range below 9 to 6 years of age, and expanding the indication from endemic populations to also include travelers to endemic areas. Cost-effectiveness may improve with the modified 2-dose regimen and with multiple testing. Strategies to implement a dengue vaccination program have been developed, in particular school-based strategies. A range of delivery scenarios can then be considered, using various settings for each step of the intervention. However, several challenges remain, including communication about limiting the use of this vaccine to seropositive individuals only. Affordability will vary from country to country, as will government commitment and community acceptance. Well-tailored communication strategies that target key stakeholders are expected to make up a significant part of any future dengue vaccination program. 相似文献
8.
9.
10.